E-cigarettes: a scientific review

Rachel Grana, Neal Benowitz, Stanton A Glantz, Rachel Grana, Neal Benowitz, Stanton A Glantz

No abstract available

Keywords: adolescent; particulate matter; public policy; smoking.

Figures

Figure 1.
Figure 1.
Examples of different electronic cigarette (e-cigarette) products. Reproduced from Grana et al.
Figure 2.
Figure 2.
Studies screened and selected for inclusion. PRISMA indicates Preferred Reporting Items for Systematic Reviews and Meta-Analyses.
Figure 3.
Figure 3.
Particle number distribution from (A) mainstream aerosol in e-liquid 1 and from (B) conventional cigarette. Reproduced from Fuoco et al with permission from the publisher. Copyright © 2013 Elsevier Ltd.

References

    1. Grana R, Benowitz N, Glantz SA. Background paper on E-cigarettes (electronic nicotine delivery systems).Center for Tobacco Control Research and Education, University of California, San Francisco, a WHO Collaborating Center on Tobacco Control. Prepared for World Health Organization Tobacco Free Initiative. December 2013. . Accessed March 31, 2014.
    1. Felberbaum M. The Associated Press.; 2013. Old Tobacco Playbook Gets New Use by E-Cigarettes. . Accessed August 16, 2013.
    1. Grana RA, Ling PM. Smoking revolution? A content analysis of electronic cigarette retail websites. Am J Prev Med. 2014;46:395–403.
    1. Adkison SE, O’Connor RJ, Bansal-Travers M, Hyland A, Borland R, Yong HH, Cummings KM, McNeill A, Thrasher JF, Hammond D, Fong GT. Electronic nicotine delivery systems: international tobacco control four-country survey. Am J Prev Med. 2013;44:207–215.
    1. King BA, Alam S, Promoff G, Arrazola R, Dube SR. Awareness and ever use of electronic cigarettes among US adults, 2010–2011. Nicotine Tob Res. 2013;15:1623–1627.
    1. Dockrell M, Morrison R, Bauld L, McNeill A. E-cigarettes: prevalence and attitudes in Great Britain. Nicotine Tob Res. 2013;15:1737–1744.
    1. Pearson JL, Richardson A, Niaura RS, Vallone DM, Abrams DB. e-Cigarette awareness, use, and harm perceptions in US adults. Am J Public Health. 2012;102:1758–1766.
    1. Regan AK, Promoff G, Dube SR, Arrazola R. Electronic nicotine delivery systems: adult use and awareness of the “e-cigarette” in the USA. Tob Control. 2013;22:19–23.
    1. Centers for Disease Control and Prevention. Notes from the field: electronic cigarette use among middle and high school students—United States, 2011–2012. Morb Mortal Wkly Rep. 2013;62:729–730.
    1. Lee S, Grana RA, Glantz SA. Electronic-cigarette use among Korean adolescents: a cross-sectional study of market penetration, dual use, and relationship to quit attempts and former smoking [published online ahead of print November 22, 2013]. J Adolesc Health. doi: 10.1016/j. jadohealth.2013.11.003. .
    1. Dutra L, Glantz SA. E-cigarettes and conventional cigarette use among U.S. adolescents: a cross-sectional study [published online ahead of print March 6, 2014]. JAMA Ped. doi: 10.1001/jamapediatrics.2013.5488. . Accessed March 6, 2013.
    1. World Health Organization. WHO Study Group on Tobacco Product Regulation: report on the scientific basis of tobacco product regulation. WHO Technical Report Series. 2009:i–21.
    1. FCTC/COP/5/13. Report: Electronic Nicotine Delivery Systems, Including Electronic Cigarettes. Seoul, Republic of Korea: 2012.
    1. Schaller K, Ruppert L, Kahnert S, Bethke C, Nair U, Pötschke-Langer M.
    1. Burstyn I. Peering through the Mist: What Does the Chemistry of Contaminants in Electronic Cigarettes Tell Us About Health Risks? Technical Report July-August 2013. . Accessed September 23, 2013.
    1. Trtchounian A, Talbot P. Electronic nicotine delivery systems: is there a need for regulation? Tob Control. 2011;20:47–52.
    1. Givens A, Cheng P-S. I-Team: E-cigarettes, used to smoke marijuana, spark new concerns. 2013. Oct 11, 4 New York. .
    1. Shuman P, Burns M. 2013. May 24, Latest cannibis craze: marijuana known as “wax.”. . .
    1. Williams M, Talbot P. Variability among electronic cigarettes in the pressure drop, airflow rate, and aerosol production. Nicotine Tob Res. 2011;13:1276–1283.
    1. US Department of Health and Human Services. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Prevention and Control, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2012. Preventing tobacco use among youth and young adults: a report of the Surgeon General.
    1. Grana RA, Glantz SA, Ling PM. Electronic nicotine delivery systems in the hands of Hollywood. Tob Control. 2011;20:425–426.
    1. de Andrade M, Hastings G, Angus K. Promotion of electronic cigarettes: tobacco marketing reinvented? BMJ. 2013;347:f7473.
    1. Rooke C, Amos A. News media representations of electronic cigarettes: an analysis of newspaper coverage in the UK and Scotland [published online ahead of print July 24, 2013]. Tob Control. doi:10.1136/tobaccocontrol-2013–051043. . Accessed September 9, 2013.
    1. Kim AE, Lee YO, Shafer P, Nonnemaker J, Makarenko O. Adult smokers’ receptivity to a television advert for electronic nicotine delivery systems [published online ahead of print October 3, 2013]. Tob Control. doi:10.1136/tobaccocontrol-2013–051130. . Accessed November 21, 2013.
    1. Brussels, Belgium: 2012. TNS Opinion & Social. Attitudes of Europeans Towards Tobacco.Special Eurobarometer 385, Wave Eb77.1 commissioned by the Directorate General Health and Consumers of the European Commission;
    1. Etter JF, Bullen C. A longitudinal study of electronic cigarette users. Addict Behav. 2014;39:491–494.
    1. Douptcheva N, Gmel G, Studer J, Deline S, Etter JF. Use of electronic cigarettes among young Swiss men. J Epidemiol Community Health. 2013;67:1075–1076.
    1. Kralikova E, Novak J, West O, Kmetova A, Hajek P. Do e-cigarettes have the potential to compete with conventional cigarettes? A survey of conventional cigarette smokers’ experiences with e-cigarettes. Chest. 2013;144:1609–1614.
    1. Etter JF, Bullen C. Electronic cigarette: users profile, utilization, satisfaction and perceived efficacy. Addiction. 2011;106:2017–2028.
    1. Goniewicz ML, Lingas EO, Hajek P. Patterns of electronic cigarette use and user beliefs about their safety and benefits: an internet survey. Drug Alcohol Rev. 2013;32:133–140.
    1. Choi K, Forster JL. Beliefs and experimentation with electronic cigarettes: a prospective analysis among young adults. Am J Prev Med. 2014;46:175–178.
    1. Reddy A.
    1. Goniewicz ML, Zielinska-Danch W. Electronic cigarette use among teenagers and young adults in Poland. Pediatrics. 2012;130:e879–e885.
    1. Utah Department of Health. Utah health status update: electronic cigarette use among Utah students (grades 8, 10, and 12) and adults. Updated December 2013. . Accessed February 2, 2014.
    1. Hadwiger ME, Trehy ML, Ye W, Moore T, Allgire J, Westenberger B. Identification of amino-tadalafil and rimonabant in electronic cigarette products using high pressure liquid chromatography with diode array and tandem mass spectrometric detection. J Chromatogr A. 2010;1217:7547–7555.
    1. Trehy ML, Ye W, Hadwiger ME, Moore TW, Allgire JF, Woodruff JT, Ahadi SS, Black JC, Westenberger BJ. Analysis of electronic cigarette cartridges, refill solutions, and smoke for nicotine and nicotine related impurities. J Liq Chromatogr Relat Technol. 2011;34:1442–1458.
    1. Goniewicz ML, Kuma T, Gawron M, Knysak J, Kosmider L. Nicotine levels in electronic cigarettes. Nicotine Tob Res. 2013;15:158–166.
    1. Cameron JM, Howell DN, White JR, Andrenyak DM, Layton ME, Roll JM. Variable and potentially fatal amounts of nicotine in e-cigarette nicotine solutions. Tob Control. 2014;23:77–78.
    1. Schober W, Szendrei K, Matzen W, Osiander-Fuchs H, Heitmann D, Schettgen T, Jorres RA, Fromme H. Use of electronic cigarettes (e-cigarettes) impairs indoor air quality and increases FeNO levels of e-cigarette consumers [published online ahead of print December 6, 2013]. Int J Hyg Environ Health. doi: 10.1016/j.ijheh.2013.11.003. . Accessed February 10, 2014.
    1. Goniewicz ML, Hajek P, McRobbie H. Nicotine content of electronic cigarettes, its release in vapour and its consistency across batches: regulatory implications. Addiction. 2014;109:500–507.
    1. Goniewicz ML, Knysak J, Gawron M, Kosmider L, Sobczak A, Kurek J, Prokopowicz A, Jablonska-Czapla M, Rosik-Dulewska C, Havel C. Levels of selected carcinogens and toxicants in vapour from electronic cigarettes. Tob Control. 2014;23:133–139.
    1. Kim HJ, Shin HS. Determination of tobacco-specific nitrosamines in replacement liquids of electronic cigarettes by liquid chromatography-tandem mass spectrometry. J Chromatogr A. 2013;1291:48–55.
    1. Bahl V, Lin S, Xu N, Davis B, Wang YH, Talbot P. Comparison of electronic cigarette refill fluid cytotoxicity using embryonic and adult models. Reprod Toxicol. 2012;34:529–537.
    1. Romagna G, Allifranchini E, Bocchietto E, Todeschi S, Esposito M, Farsalinos KE. Cytotoxicity evaluation of electronic cigarette vapor extract on cultured mammalian fibroblasts (ClearStream-LIFE): comparison with tobacco cigarette smoke extract. Inhal Toxicol. 2013;25:354–361.
    1. Farsalinos KE, Romagna G, Allifranchini E, Ripamonti E, Bocchietto E, Todeschi S, Tsiapras D, Kyrzopoulos S, Voudris V. Comparison of the cytotoxic potential of cigarette smoke and electronic cigarette vapour extract on cultured myocardial cells. Int J Environ Res Public Health. 2013;10:5146–5162.
    1. Schripp T, Markewitz D, Uhde E, Salthammer T. Does e-cigarette consumption cause passive vaping? Indoor Air. 2013;23:25–31.
    1. Flouris AD, Chorti MS, Poulianiti KP, Jamurtas AZ, Kostikas K, Tzatzarakis MN, Wallace Hayes A, Tsatsakis AM, Koutedakis Y. Acute impact of active and passive electronic cigarette smoking on serum cotinine and lung function. Inhal Toxicol. 2013;25:91–101.
    1. Armitage AK, Dollery CT, George CF, Houseman TH, Lewis PJ, Turner DM. Absorption and metabolism of nicotine from cigarettes. Br Med J. 1975;4:313–316.
    1. Czogala J, Goniewicz ML, Fidelus B, Zielinska-Danch W, Travers MJ, Sobczak A. Secondhand exposure to vapors from electronic cigarettes [published online ahead of print December 11, 2013]. Nicotine Tob Res. doi: 10.1093/ntr/ntt203. . Accessed February 12, 2014.
    1. Ostro B, Feng WY, Broadwin R, Green S, Lipsett M. The effects of components of fine particulate air pollution on mortality in California: results from CALFINE. Environ Health Perspect. 2007;115:13–19.
    1. Secondhand Smoke Exposure and Cardiovascular Effects: Making Sense of the Evidence. Washington, DC:: Institute of Medicine; 2010.
    1. Brook RD, Rajagopalan S, Pope CA, Brook JR, Bhatnagar A, Diez-Roux AV, Holguin F, Hong Y, Luepker RV, Mittleman MA. Particulate matter air pollution and cardiovascular disease: an update to the scientific statement from the American Heart Association. Circulation. 2010;121:2331–2378.
    1. Pope CA, 3rd, Burnett RT, Krewski D, Jerrett M, Shi Y, Calle EE, Thun MJ. Cardiovascular mortality and exposure to airborne fine particulate matter and cigarette smoke: shape of the exposure-response relationship. Circulation. 2009;120:941–948.
    1. Mehta S, Shin H, Burnett R, North T, Cohen AJ. Ambient particulate air pollution and acute lower respiratory infections: a systematic review and implications for estimating the global burden of disease. Air Qual Atmos Health. 2013:1–15.
    1. Fuoco FC, Buonanno G, Stabile L, Vigo P. Influential parameters on particle concentration and size distribution in the mainstream of e-cigarettes. Environ Pollut. 2014;184:523–529.
    1. Ingebrethsen BJ, Cole SK, Alderman SL. Electronic cigarette aerosol particle size distribution measurements. Inhal Toxicol. 2012;24:976–984.
    1. Zhang Y, Sumner W, Chen DR. In vitro particle size distributions in electronic and conventional cigarette aerosols suggest comparable deposition patterns. Nicotine Tob Res. 2013;15:501–508.
    1. Williams M, Villarreal A, Bozhilov K, Lin S, Talbot P. Metal and silicate particles including nanoparticles are present in electronic cigarette cartomizer fluid and aerosol. PLoS One. 2013;8:e57987.
    1. Vansickel AR, Cobb CO, Weaver MF, Eissenberg TE. A clinical laboratory model for evaluating the acute effects of electronic “cigarettes”: nicotine delivery profile and cardiovascular and subjective effects. Cancer Epidemiol Biomarkers Prev. 2010;19:1945–1953.
    1. Bullen C, McRobbie H, Thornley S, Glover M, Lin R, Laugesen M. Effect of an electronic nicotine delivery device (e cigarette) on desire to smoke and withdrawal, user preferences and nicotine delivery: randomised cross-over trial. Tob Control. 2010;19:98–103.
    1. Etter JF, Bullen C. Saliva cotinine levels in users of electronic cigarettes. Eur Respir J. 2011;38:1219–1220.
    1. Vansickel AR, Eissenberg T. Electronic cigarettes: effective nicotine delivery after acute administration. Nicotine Tob Res. 2013;15:267–270.
    1. Dawkins L, Corcoran O. Acute electronic cigarette use: nicotine delivery and subjective effects in regular users. Psychopharmacology. 2013:1–7.
    1. Dawkins L, Turner J, Hasna S, Soar K. The electronic-cigarette: effects on desire to smoke, withdrawal symptoms and cognition. Addict Behav. 2012;37:970–973.
    1. Nides MA, Leischow SJ, Bhatter M, Simmons M. Nicotine blood levels and short-term smoking reduction with an electronic nicotine delivery system. Am J Health Beh. 2014;38:265–274.
    1. , Inc.
    1. Dow Chemical Co. Product Safety Assessment (PSA): propylene glycol. 2013. .
    1. The American Chemistry Council. Propylene glycol: considerations against use in theatrical fogs. 2001. . Accessed November 21, 2013.
    1. Laino T, Tuma C, Moor P, Martin E, Stolz S, Curioni A. Mechanisms of propylene glycol and triacetin pyrolysis. J Phys Chem A. 2012;116:4602–4609.
    1. US Environmental Protection Agency. Acrolein. .
    1. Henderson TR, Clark CR, Marshall TC, Hanson RL, CH H. Heat degradation studies of solar heat transfer fluids. Solar Energy. 1981;27:121–128.
    1. Chen IL. FDA summary of adverse events on electronic cigarettes. Nicotine Tob Res. 2013;15:615–616.
    1. CBS News. Electronic cigarette explodes in man’s mouth, causes serious injuries. February 16, 2012. . Accessed November 24, 2013.
    1. Strickland J. WSB-TV Atlanta; 2013. Woman says e-cigarette exploded, shot flames 4 feet across living room. .
    1. Vardavas CI, Anagnostopoulos N, Kougias M, Evangelopoulou V, Connolly GN, Behrakis PK. Short-term pulmonary effects of using an electronic cigarette: impact on respiratory flow resistance, impedance, and exhaled nitric oxide. Chest. 2012;141:1400–1406.
    1. Flouris AD, Poulianiti KP, Chorti MS, Jamurtas AZ, Kouretas D, Owolabi EO, Tzatzarakis MN, Tsatsakis AM, Koutedakis Y. Acute effects of electronic and tobacco cigarette smoking on complete blood count. Food Chem Toxicol. 2012;50:3600–3603.
    1. McAuley TR, Hopke PK, Zhao J, Babaian S. Comparison of the effects of e-cigarette vapor and cigarette smoke on indoor air quality. Inhal Toxicol. 2012;24:850–857.
    1. Medicines and Healthcare Products Regulatory Agency. London, UK: Public Summary Report, Medicines and Healthcare Products Regulatory Agency; 2013. Jun 12, The Regulation of Nicotine Containing Products (NCPS).
    1. Grana R, Popova L, Ling P. A longitudinal analysis of electronic cigarette use and smoking cessation [published online ahead of print March 24, 2014]. JAMA Int Med. doi:10.1001/jamainternmed.2014.187. . Accessed March 24, 2014.
    1. Vickerman KA, Carpenter KM, Altman T, Nash CM, Zbikowski SM. Use of electronic cigarettes among state tobacco cessation quitline callers. Nicotine Tob Res. 2013;15:1787–1791.
    1. Choi K, Forster JL. Response to Letter to the Editor Regarding “Beliefs and Experimentation with Electronic Cigarettes: A Prospective Analysis Among Young Adults.”. Am J Prev Med
    1. Popova L, Ling PM. Alternative tobacco product use and smoking cessation: a national study. Am J Public Health. 2013;103:923–930.
    1. Polosa R, Caponnetto P, Morjaria JB, Papale G, Campagna D, Russo C. Effect of an electronic nicotine delivery device (e-cigarette) on smoking reduction and cessation: a prospective 6-month pilot study. BMC Public Health. 2011;11:786.
    1. Caponnetto P, Campagna D, Cibella F, Morjaria JB, Caruso M, Russo C, Polosa R. EffiCiency and Safety of an eLectronic cigAreTte (ECLAT) as tobacco cigarettes substitute: a prospective 12-month randomized control design study. PLoS One. 2013;8:e66317.
    1. Caponnetto P, Auditore R, Russo C, Cappello GC, Polosa R. Impact of an electronic cigarette on smoking reduction and cessation in schizophrenic smokers: a prospective 12-month pilot study. Int J Environ Res Public Health. 2013;10:446–461.
    1. Bullen C, Howe C, Laugesen M, McRobbie H, Parag V, Williman J, Walker N. Electronic cigarettes for smoking cessation: a randomised controlled trial. Lancet. 2013;382:1629–1637.
    1. Polosa R, Morjaria JB, Caponnetto P, Campagna D, Russo C, Alamo A, Amaradio M, Fisichella A. Effectiveness and tolerability of electronic cigarette in real-life: a 24-month prospective observational study. Intern Emerg Med. 2013:1–10.
    1. Hughes JR, Shiffman S, Callas P, Zhang J. A meta-analysis of the efficacy of over-the-counter nicotine replacement. Tob Control. 2003;12:21–27.
    1. Eissenberg T. Electronic nicotine delivery devices: ineffective nicotine delivery and craving suppression after acute administration. Tob Control. 2010;19:87–88.
    1. Moore D, Aveyard P, Connock M, Wang D, Fry-Smith A, Barton P. Effectiveness and safety of nicotine replacement therapy assisted reduction to stop smoking: systematic review and meta-analysis. BMJ. 2009;338:b1024.
    1. Godtfredsen N, Osler M, Vestbo J, Andersen I, Prescott E. Smoking reduction, smoking cessation, and incidence of fatal and non-fatal myocardial infarction in Denmark 1976–1998: a pooled cohort study. J Epidemiol Commun Health. 2003;57:412–416.
    1. Jha P, Ramasundarahettige C, Landsman V, Rostron B, Thun M, Anderson RN, McAfee T, Peto R. 21st-Century hazards of smoking and benefits of cessation in the United States. N Engl J Med. 2013;368:341–350.
    1. Gerber Y, Myers V, Goldbourt U. Smoking reduction at midlife and lifetime mortality risk in men: a prospective cohort study. Am J Epidemiol. 2012;175:1006–1012.
    1. Tverdal A, Bjartveit K. Health consequences of reduced daily cigarette consumption. Tob Control. 2006;15:472–480.
    1. US Department of Health and Human Services. The Health Consequences of Smoking: 50 Years of Progress: A Report of the Surgeon General. Atlanta, GA: Centers for Disease Control and Prevention, National Center on Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2014.
    1. Barnoya J, Glantz SA. Cardiovascular effects of secondhand smoke: nearly as large as smoking. Circulation. 2005;111:2684–2698.
    1. Bjartveit K, Tverdal A. Health consequences of smoking 1-4 cigarettes per day. Tob Control. 2005;14:315–320.
    1. Thun MJ, Carter BD, Feskanich D, Freedman ND, Prentice R, Lopez AD, Hartge P, Gapstur SM. 50-Year trends in smoking-related mortality in the United States. N Engl J Med. 2013;368:351–364.
    1. Lynch SM, Vrieling A, Lubin JH, Kraft P, Mendelsohn JB, Hartge P, Canzian F, Steplowski E, Arslan AA, Gross M, Helzlsouer K, Jacobs EJ, LaCroix A, Petersen G, Zheng W, Albanes D, Amundadottir L, Bingham SA, Boffetta P, Boutron-Ruault MC, Chanock SJ, Clipp S, Hoover RN, Jacobs K, Johnson KC, Kooperberg C, Luo J, Messina C, Palli D, Patel AV, Riboli E, Shu XO, Rodriguez Suarez L, Thomas G, Tjønneland A, Tobias GS, Tong E, Trichopoulos D, Virtamo J, Ye W, Yu K, Zeleniuch-Jacquette A, Bueno-de-Mesquita HB, Stolzenberg-Solomon RZ. Cigarette smoking and pancreatic cancer: a pooled analysis from the pancreatic cancer cohort consortium. Am J Epidemiol. 2009;170:403–413.
    1. Pandeya N, Williams GM, Sadhegi S, Green AC, Webb PM, Whiteman DC. Associations of duration, intensity, and quantity of smoking with adenocarcinoma and squamous cell carcinoma of the esophagus. Am J Epidemiol. 2008;168:105–114.
    1. Vineis P, Kogevinas M, Simonato L, Brennan P, Boffetta P. Levelling-off of the risk of lung and bladder cancer in heavy smokers: an analysis based on multicentric case-control studies and a metabolic interpretation. Mutat Res. 2000;463:103–110.
    1. Doll R, Peto R. Cigarette smoking and bronchial carcinoma: dose and time relationships among regular smokers and lifelong non-smokers. J Epidemiol Community Health. 1978;32:303–313.
    1. Flanders WD, Lally CA, Zhu BP, Henley SJ, Thun MJ. Lung cancer mortality in relation to age, duration of smoking, and daily cigarette consumption: results from Cancer Prevention Study II. Cancer Res. 2003;63:6556–6562.
    1. Fiore M. Treating Tobacco Use and Dependence: 2008 Update: Clinical Practice Guideline. Darby, PA: DIANE Publishing; 2008.
    1. Esterl M. Lorillard isn’t backing away from menthol or e-cigarettes. Wall Street J. 2013 Aug 27; . Accessed November 24, 2013.
    1. Kessler MS. E-cigarettes could reduce harm: opposing view: regulatory actions, including tax policy should encourage cigarette smokers to switch. USA Today. 2013 Sep 22; . Accessed November 24, 2013.
    1. Peeters S, Gilmore AB. Transnational tobacco company interests in smokeless tobacco in Europe: analysis of internal industry documents and contemporary industry materials. PLoS Med. 2013;10:e1001506.
    1. Peeters S, Gilmore AB. Understanding the emergence of the tobacco industry’s use of the term tobacco harm reduction in order to inform public health policy [published online ahead of print January 22, 2014]. Tob Control. doi: 10.1136/tobaccocontrol-2013-051502. . Accessed February 2, 2014.
    1. US Department of Health and Human Services. How Tobacco Smoke Causes Disease: The Biology and Behavioral Basis for Smoking-Attributable Disease: A Report of the Surgeon General. Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2010.
    1. Samuels B, Glantz SA. The politics of local tobacco control. JAMA. 1991;266:2110–2117.
    1. Fallin A, Grana R, Glantz SA. To quarterback behind the scenes, third-party efforts”: the tobacco industry and the tea party [published online ahead of print February 20, 2013]. Tob Control. doi:10.1136/tobaccocontrol-2012–050815. .
    1. Higgins A. Aided by army of “’vapers,” e-cigarette industry woos and wins Europe. The New York Times. 2013 . Accessed November 12, 2013.
    1. Sottera, Inc. v Food & Drug Administration. (2010)
    1. American Nonsmokers’ Rights Foundation. U.S. state and local laws regulating use of electronic cigarettes. 2013. Oct 1, . Accessed December 14, 2013.
    1. European Parliament and European Council of the European Union. Directive of the European Parliament and of the Council on the Approximation of the Laws, Regulations, and Administrative Provisions of the Member States concerning the manufacture, presentation and sale of tobacco and related products. Pe-Cons No/Yy - 2012/0366 (Cod) 2014. Feb 26, . Accessed March 25, 2014.
    1. European Commission. Memo: questions & answers: new rules for tobacco products. 2014. . Accessed March 5, 2014.
    1. Medicines and Healthcare Products Regulatory Agency. The regulation of nicotine containing products: questions and answers. 2013. . Accessed October 4, 2013.
    1. Action on Smoking and Health. Electronic cigarettes. 2013. . Accessed October 4, 2013.
    1. McKee M. E-cigarettes and the marketing push that surprised everyone. BMJ. 2013;347:f5780.
    1. Dwyer JB, Broide RS, Leslie FM. Nicotine and brain development. Birth Defects Res C Embryo Today. 2008;84:30–44.
    1. Liao C-Y, Chen Y-J, Lee J-F, Lu C-L, Chen C-H. Cigarettes and the developing brain: picturing nicotine as a neuroteratogen using clinical and preclinical studies. Tzu Chi Med J. 2012;24:157–161.
    1. Lichtensteiger W, Ribary U, Schlumpf M, Odermatt B, Widmer HR. Prenatal adverse effects of nicotine on the developing brain. Prog Brain Res. 1988;73:137–157.
    1. Longo CA, Fried PA, Cameron I, Smith AM. The long-term effects of prenatal nicotine exposure on response inhibition: an fMRI study of young adults. Neurotoxicol Teratol. 2013;39:9–18.
    1. US Department of Health and Human Services. The Health Consequences of Involuntary Exposure to Tobacco Smoke: A Report of the Surgeon General. Washington, DC: Department of Health and Human Services PHS, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office of Smoking and Health; 2006.
    1. Fichtenberg CM, Glantz SA. Effect of smoke-free workplaces on smoking behaviour: systematic review. BMJ. 2002;325:188.
    1. Tan CE, Glantz SA. Association between smoke-free legislation and hospitalizations for cardiac, cerebrovascular, and respiratory diseases: a meta-analysis. Circulation. 2012;126:2177–2183.

Source: PubMed

Sponsoren und Mitarbeiter

Krankheiten

Drogeninterventionen

3
Abonnieren